cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Edgewise Therapeutics Inc
1 own
3 watching
Current Price
$10.75
$-0.05
(-0.46%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
679.49M
52-Week High
52-Week High
14.33
52-Week Low
52-Week Low
5.405
Average Volume
Average Volume
0.12M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization679.49M
icon52-Week High14.33
icon52-Week Low5.405
iconAverage Volume0.12M
iconDividend Yield--
iconP/E Ratio--
What does the Edgewise Therapeutics Inc do?
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company s lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.
Read More
How much money does Edgewise Therapeutics Inc make?
News & Events about Edgewise Therapeutics Inc.
Business Wire
1month ago
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, targeted, small molecule therapies for the treatment of devastating muscle disorders, today announced that management will present at the J.P. Morgan 41st Annual...
Business Wire
1month ago
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, targeted, small molecule therapies for the treatment of devastating muscle disorders, announced today plans to host a virtual investor call on Tuesday, January 3, 2023...
Business Wire
1month ago
Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, targeted, small molecule therapies for individuals with devastating muscle disorders, announced today the appointment of Marc Semigran, M.D., as Chief Development...
Business Wire
2 months ago
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the treatment of rare muscle disorders, announced today that members of its senior management team will participate in the following...
Business Wire
4 months ago
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) today announced the pricing of its upsized underwritten public offering of 11,627,907 shares of its common stock at a price to the public of $10.32 per share. All of the shares are to be sold by Edgewise Therapeutics. In addition, Edgewise Therapeutics has...
Frequently Asked Questions
Frequently Asked Questions
What is Edgewise Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Edgewise Therapeutics Inc shares?
plus_minus_icon
How can I buy Edgewise Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Edgewise Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Edgewise Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Edgewise Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Edgewise Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Edgewise Therapeutics Inc?
plus_minus_icon
What percentage is Edgewise Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Edgewise Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$10.75
$-0.05
(-0.46%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00